Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 297.75
+2.50 (0.85%)
Aug 28, 2026, 2:24 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.31 trillion as of August 28, 2026. Its market cap has decreased by -17.61% in one year.
Market Cap
1.31T
Enterprise Value
1.40T
Revenue
329.43B
Ranking
n/a
PE Ratio
11.27
Stock Price
297.75
ChartMarket Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.31T, an increase of 2,738.66%. That is a compound annual growth rate of 11.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 1.31T | -9.65% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genmab | 129.37B |
| Coloplast | 103.35B |
| Demant | 60.32B |
| ALK-Abelló | 47.08B |
| H. Lundbeck | 41.38B |
| Zealand Pharma | 21.59B |
| Ambu A/S | 18.51B |
| Bavarian Nordic | 16.13B |